Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase III Trial to Test the Efficacy of ZD4054(Zibotentan), an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
INTERVENTIONAL
Inicio: 1 de nov de 2007
ID: NCT00554229
Completado
Fase 3
ClinicalTrials.gov
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Trial
INTERVENTIONAL
Inicio: 2 de dic de 2008
ID: NCT00988429
Completado
Fase 3
ClinicalTrials.gov
A Multinational, Randomized, Double-blind, Placebo-controlled, Forced-titration, 2 x 2 Factorial Design Study of the Efficacy and Safety of Long-term Administration of Nateglinide and Valsartan in the Prevention of Diabetes and Cardiovascular Outcomes in Subjects With Impaired Glucose Tolerance (IGT)
INTERVENTIONAL
Inicio: 1 de ene de 2002
ID: NCT00097786
Terminado
ClinicalTrials.gov
Two Bag System vs. One Bag System for Hydration Patients With Diabetic Ketoacidosis
INTERVENTIONAL
Inicio: 1 de ago de 2012
ID: NCT01631929
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Dose-ranging Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus
INTERVENTIONAL
Inicio: 31 de mar de 2011
ID: NCT01283139
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)
INTERVENTIONAL
Inicio: 2 de mar de 2017
ID: NCT03057951
Completado
ClinicalTrials.gov
Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina
OBSERVATIONAL
Inicio: 10 de jul de 2020
ID: NCT04362956
Completado
ClinicalTrials.gov
Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms. (CAC-TRAIT Study)
OBSERVATIONAL
Inicio: 7 de nov de 2022
ID: NCT05619042
Completado
Fase 4
ClinicalTrials.gov
A 48 Week Extension to CTBM100C2401, a Single Arm, Open-label, Multicenter, Phase IV Extension Trial to Assess Long Term Safety of Tobramycin Inhalation Powder (TIP) in Patients With Cystic Fibrosis Who Completed Participation in CTBM100C2401.
INTERVENTIONAL
Inicio: 1 de feb de 2013
ID: NCT01775137
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)
INTERVENTIONAL
Inicio: 2 de may de 2020
ID: NCT04362137
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Adult Patients With Moderate to Severe Atopic Dermatitis BREEZE-AD7
INTERVENTIONAL
Inicio: 16 de nov de 2018
ID: NCT03733301
Completado
Fase 2
ClinicalTrials.gov
Open-label, Multicenter, Phase II Immunotherapy Study With Racotumomab in Patients With High-risk Neuroblastoma
INTERVENTIONAL
Inicio: 1 de nov de 2016
ID: NCT02998983
Completado
Fase 3
ClinicalTrials.gov
An Open-label, Multi-center, Three Arm Randomized Study to Investigate the Safety and Efficacy on Progression-free Survival of RO5072759 + Chlorambucil (GClb) Compared to Rituximab + Chlorambucil (RClb) or Chlorambucil (Clb) Alone in Previously Untreated CLL Patients With Comorbidities.
INTERVENTIONAL
Inicio: 21 de dic de 2009
ID: NCT01010061
Desconocido
Fase 3
ClinicalTrials.gov
MULTICENTER, RANDOMIZED, DOUBLE BLIND, CONTROLLED, CLINICAL STUDY TO DEMONSTRATE THE THERAPEUTIC CLINICAL EQUIVALENCE OF TWO MOMETASONE NASAL SPRAYS IN THE RELIEF OF THE SIGNS AND SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS.
INTERVENTIONAL
Inicio: 1 de oct de 2012
ID: NCT01702103
Completado
Fase 3
ClinicalTrials.gov
A 24-week, Multicentre, Randomised, Double-blind,Age-stratified, Placebo Controlled Phase III Study With an 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Patients With T2DM and Cardiovascular Disease, Who Exhibit Inadequate Glycaemic Control on Usual Care
INTERVENTIONAL
Inicio: 1 de mar de 2010
ID: NCT01042977
Completado
ClinicalTrials.gov
A Multicenter, Global, Retrospective, Observational Study to Characterize Real-world Clinical Outcomes in Patients With Relapsing-remitting Multiple Sclerosis Treated With Disease-modifying Therapies (Tecfidera®, Copaxone®, Aubagio®, or Gilenya®)
OBSERVATIONAL
Inicio: 1 de may de 2016
ID: NCT02776072
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind Study of Nivolumab or Placebo in Combination With Docetaxel, in Men With Metastatic Castration-resistant Prostate Cancer
INTERVENTIONAL
Inicio: 6 de feb de 2020
ID: NCT04100018
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function
INTERVENTIONAL
Inicio: 19 de dic de 2017
ID: NCT03315143
Completado
Fase 3
ClinicalTrials.gov
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 26 de jul de 2015
ID: NCT02420262
Terminado
Fase 3
ClinicalTrials.gov
An Open-Label, Single-Arm Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis
INTERVENTIONAL
Inicio: 24 de mar de 2017
ID: NCT03085810
Anterior
1
...
419
420
421
...
434
Siguiente
Filtros